Background-Hypoxic vasodilation is a physiological response to low oxygen tension that increases blood supply to match metabolic demands. Although this response has been characterized for Ͼ100 years, the underlying hypoxic sensing and effector signaling mechanisms remain uncertain. We have shown that deoxygenated myoglobin in the heart can reduce nitrite to nitric oxide (NO ⅐ ) and thereby contribute to cardiomyocyte NO ⅐ signaling during ischemia. On the basis of recent observations that myoglobin is expressed in the vasculature of hypoxia-tolerant fish, we hypothesized that endogenous nitrite may contribute to physiological hypoxic vasodilation via reactions with vascular myoglobin to form NO ⅐ . Methods and Results-We show in the present study that myoglobin is expressed in vascular smooth muscle and contributes significantly to nitrite-dependent hypoxic vasodilation in vivo and ex vivo. The generation of NO ⅐ from nitrite reduction by deoxygenated myoglobin activates canonical soluble guanylate cyclase/cGMP signaling pathways. In vivo and ex vivo vasodilation responses, the reduction of nitrite to NO ⅐ , and the subsequent signal transduction mechanisms were all significantly impaired in mice without myoglobin. Hypoxic vasodilation studies in myoglobin and endothelial and inducible NO synthase knockout models suggest that only myoglobin contributes to systemic hypoxic vasodilatory responses in mice. Conclusions-Endogenous nitrite is a physiological effector of hypoxic vasodilation. Its reduction to NO ⅐ via the heme globin myoglobin enhances blood flow and matches O 2 supply to increased metabolic demands under hypoxic conditions. (Circulation. 2012;126:325-334.)
H ypoxic vasodilation occurs as an adaptive response to a developing imbalance between demand and supply for O 2 . This mechanism ensures an adequate increase of local blood flow to fulfill the need for delivery of O 2 to metabolically active tissue. This response is critical for exercising muscle, for adaptation to high altitude, and for the regulation of perfusion during embryonic development. 1 Hypoxic vasodilation occurs in conduit [2] [3] [4] [5] [6] and resistance-size arteries. 6 -9 Although this response has been characterized in the coronary circulation since 1879, the hypoxic sensor and the coupled vasodilatory effector of this response remain elusive. Various effectors for this response have been suggested, ranging from hydrogen ion concentration 10 to local mediators such as adenosine and ATP-sensitive potassium channels, as well as prostacyclin. 11, 12 Nitric oxide (NO ⅐ ) is known to contribute to the mechanism of hypoxic vasodilation via the downstream activation of an extended signaling pathway, which culminates in the decrease of intracellular [Ca 2ϩ ] in smooth muscle cells and relaxation of vascular tone. [13] [14] [15] The origin of NO ⅐ under hypoxia, however, has not yet been formally identified, although the source of NO ⅐ contributing to normoxic vasodilation is widely believed to be endothelial NO synthase (eNOS). 16 However, NO ⅐ formation by eNOS requires O 2 , with a K m estimated at 25 to 100 mol/L O 2 , suggesting that under hypoxic conditions, NO ⅐ formation by eNOS would decrease rather than increase. Moreover, eNOS does not possess an intrinsic mechanism for increased NO ⅐ production in response to hypoxia, suggesting that NOS-independent NO ⅐ formation pathways are more likely to determine hypoxic responses.
Clinical Perspective on p 334
High concentrations of the inorganic anion nitrite have been known to be vasoactive for many years. 17 Indeed, millimolar to high micromolar pharmacological concentrations of exogenous nitrite have been demonstrated to relax preconstricted isolated vessels. 5, 17, 18 Unexpectedly, it has been shown more recently that nitrite functions as a more potent vasodilator under mild hypoxic or acidic conditions and in the human circulation. 4, 5, 19 Moreover, hypoxia effectively enhances the effects of exogenously administered nitrite. 4, 5, 19, 20 The pioneering study from Cosby and coworkers 4 revealed a striking effect of nitrite infusions on systemic blood flow in normal human volunteers at near physiological nitrite concentrations. The vasodilation was inversely correlated with hemoglobin O 2 saturation and directly correlated with the formation of NO-modified hemoglobin (ironnitrosylated hemoglobin and, to a lesser extent, S-nitrosated hemoglobin). These results were recapitulated in aortic ring preparations, in which the addition of nitrite to deoxyhemoglobin and deoxygenated erythrocytes resulted in vessel relaxation. 4 Furthermore, reactions between nitrite and hemoglobin in isolated aortic rings along physiological hemoglobin fractional O 2 saturations exhibited a distinct interaction: Nitrite-dependent vasodilation is inhibited at high hemoglobin O 2 fractional saturation, whereas vasodilation is promoted when hemoglobin unloads to 50% saturation. 21 Taken together, these findings and the ability of hemoglobin to reduce nitrite to NO ⅐ in vitro, as shown by Brooks 22 and Doyle et al, 23 suggested a role of hemoglobin and of the heme globin family more generally in exogenous nitrite-mediated hypoxic vasodilation. 24 After these investigations of hemoglobin, our groups have shown that myoglobin and neuroglobin also react with and reduce nitrite to NO ⅐ , suggesting a generalizable biological role for heme globins in hypoxic NO ⅐ signaling. 4, [25] [26] [27] [28] Importantly, myoglobin reduces nitrite to NO ⅐ 60 times faster than deoxyhemoglobin as a result of its low heme redox potential. 27 Although the biochemical reaction mechanisms between nitrite and these heme globins have been thoroughly characterized, the NO ⅐ produced via these reactions will bind to excess deoxyhemoglobin or deoxymyoglobin to form an iron-nitrosyl complex, effectively limiting NO ⅐ signaling. For this reason, the notion that heme globins can signal via nitrite reduction has remained controversial. Whereas other enzymes, such as eNOS and xanthine oxidoreductase (XOR), have been shown to reduce nitrite to NO ⅐ at low O 2 tensions and pH values, the inhibition of both eNOS and XOR does not block nitritedependent vasodilation in the human circulation. 4, 29 The availability of a viable myoglobin-deficient (Mb Ϫ/Ϫ ) mouse model allows for more definitive testing of these still controversial candidate pathways. Using this model, we have shown that myoglobin is required for hypoxic and ischemic nitrite signaling in the heart. The reduction of exogenous nitrite by cardiac myoglobin mediates cardioprotection during ischemia and reperfusion. 26, 30 Myoglobin-dependent nitrite reduction to NO ⅐ regulates O 2 consumption under moderate hypoxia, 25, 26 and this limits the generation of reactive oxygen species under ischemia. 30 Despite the widely held belief that myoglobin is expressed only in oxidative striated and cardiac myocytes, it is now known to be localized in a wide variety of tissues, 31 including smooth muscles, 32 with as yet unidentified physiological functions. It is therefore tempting to speculate that nitrite-deoxymyoglobin interactions occur in the vasculature and contribute to hypoxic vasodilation. Over a decade, studies using particularly low concentrations of nitrite infusions in humans have shown vasodilatory effects for the naturally occurring anion nitrite. 4, 5, 19, 20 In addition, dietary approaches using nitrate to elevate circulating nitrite levels are emerging as a potential treatment regimen for high blood pressure. 20 Although these studies have provided increasing evidence that the reduction of exogenous nitrite may be an essential trigger mechanism for vasodilation under hypoxic conditions, the role of endogenous nitrite in the regulation of hypoxic vasodilation and the resulting impact on blood pressure remain uncertain. Taking advantage of the Mb Ϫ/Ϫ mouse, in the present study we demonstrate that endogenous nitrite is activated by myoglobin in vascular tissue and that this cross talk is relevant under physiological conditions.
Methods

Assessment of In Vivo Hemodynamics
Mice were anesthetized by intraperitoneal injection of ketamine (45 mg/kg) and xylazine (Rompun, 10 mg/kg). A tracheal tube was inserted, and mechanical ventilation was initiated according to body weight (volume-controlled ventilation; Inspira, Harvard Apparatus, March-Hugstetten, Germany). Ventilation was controlled by end-tidal capnography (Hugo Sachs, March-Hugstetten, Germany). Isoflurane 1.2 vol% was added as anesthetic to O 2 and nitrogen. A pressure-volume catheter (Millar Instruments, Seeheim-Ober Beerbach, Germany) was inserted via the right carotid artery into the thoracic aorta, and heparin (70 IU/kg) was injected intraperitoneally. Heart rate and systolic and diastolic blood pressures were recorded beat to beat.
To assess basal hypoxic vasodilation, hypoxia was induced by ventilation with 10% O 2 /90% N 2 , and the effects on hemodynamics were recorded continuously without the administration of exogenous nitrite. We measured heart functions through a pressure-volume catheter placed in the left ventricle (1.4F, Millar Instruments).
To investigate the effects on blood pressure of increased nitrite levels by adding exogenous nitrite under steady state hypoxia, we first injected the NOS inhibitor L-NIO (100 mg/kg IP) to inhibit endogenous NO ⅐ synthesis via NOS and unmask the genuine effects of exogenous nitrite. 4 After 30 minutes, we injected nitrite (1.67 or 16.7 mol/kg) intravenously and measured hemodynamics for the following 20 minutes. For the hypoxic experiments, the ventilation gas mixture was changed to 10% O 2 /90% N 2 after the injection of NOS inhibitor. Hypoxic ventilation was conducted for 30 minutes to establish steady state conditions before nitrite was injected.
Final blood gas composition was determined (Siemens Blood Gas Analyzer 865, Eschborn, Germany) in all in vivo experiments (steady state hypoxia with exogenous nitrite and basal hypoxic vasodilation), and only those animals with a PO 2 of 36Ϯ6 mm Hg (SD) and with normal CO 2 and pH were included.
Supplemental Methodology
For a detailed explanation of the methods applied to determine myoglobin gene regulation, to demonstrate myoglobin mRNA and protein in situ, to investigate vascular myoglobin nitrite-reductase activity, to analyze cGMP formation, to measure nitrite-derived NO ⅐ and nitrite, as well as for aortic ring bioassay and the assessment of downstream signaling pathways, please see the Methods section of the online-only Data Supplement.
Statistical Analysis
Descriptive statistics such as meanϮSD or meanϮSEM were used to summarize continuous variables. The data were analyzed by Student t test (2 groups) and ANOVA (multiple groups) with post hoc Bonferroni adjustment with the use of statistical software Prism 5.0 (GraphPad) and Sigma Plot 11 (SigmaPlot). Two-way ANOVA (for [1] mouse species and [2] time) with pairwise comparisons (HolmSidak procedure) was used for comparisons of in vivo basal hypoxic vasodilation. PϽ0.05 was considered statistically significant. However, given the smaller sample size of some approaches (nϭ3), P values should not be overinterpreted.
Results
Myoglobin Is Expressed in Vascular Smooth Muscle and Reduces Nitrite to NO ⅐
The expression of myoglobin transcript in mouse aortic tissue was confirmed by 2 methods. First, we used reverse transcription polymerase chain reaction, checked by sequencing, to demonstrate the presence of myoglobin RNA transcripts in mouse vascular tissue (data not shown). Second, we used RNA in situ hybridization of an antisense riboprobe directed against the murine myoglobin transcript to identify the smooth muscle cells of the media as the source of myoglobin mRNA ( Figure 1A ). The corresponding sense riboprobe was inactive ( Figure I of the online-only Data Supplement), and no signal was obtained in Mb Ϫ/Ϫ mice ( Figure 1B ). The presence of myoglobin protein was confirmed with the use of both immunohistology, with the use of a custom-made polyclonal antibody directed against the C-terminus of mouse myoglobin ( Figure 1C and 1D ; negative controls are shown in Figure  I in the online-only Data Supplement), and Western blotting ( Figure 1E ). Figure 1C through 1E shows that aortas from Mb ϩ/ϩ mice contain myoglobin (namely, in all smooth muscle cells); vessels from Mb Ϫ/Ϫ mice did not exhibit a signal. We then examined whether vascular tissue can generate NO ⅐ from nitrite under hypoxia and whether this was dependent on the presence of deoxymyoglobin. Homogenates of mouse aortas were added to a phosphate-buffered saline solution (pH 5.5) containing nitrite (100 mol/L, final) under anaerobic conditions, and the sustained release of NO ⅐ was monitored by headspace gas-phase chemiluminescence. Figure 1F shows that the rate of NO ⅐ release from aortas of Mb Ϫ/Ϫ mice was substantially lower than for Mb ϩ/ϩ mice. Figure 1G shows that the inhibition of XOR, by simultaneous addition of its inhibitors allopurinol (100 mol/L) and diphenyliodonium (10 mol/L) and inhibition of the electron transfer from ubiquinol to bc1 complex in the mitochondrial respiratory chain by incubation with 300 mol/L myxothiazol, had no effect in Mb ϩ/ϩ and Mb Ϫ/Ϫ tissue, consistent with a negligible contribution in previous observations. 26, 33, 34 Preincubation with 50 mmol/L ferricyanide to oxidize all cellular heme proteins significantly reduced the rate of NO ⅐ generation in Mb ϩ/ϩ . By contrast, no significant NO ⅐ release from nitrite from aortic tissues was detected under normoxia (data not shown). Figure 1H shows that addition of 20 mol/L hemoglobin did not significantly affect the rate of NO ⅐ generation in both Mb ϩ/ϩ and Mb Ϫ/Ϫ tissue. However, we observed a tendency to greater rates of NO ⅐ release in the Mb Ϫ/Ϫ group, and therefore a statistical analysis of the Mb Ϫ/Ϫ approaches was conducted. This revealed a small but significant increase of nitrite reduction in Mb Ϫ/Ϫ tissue after incubation with hemoglobin, which is consistent with our previously reported observations under the same experimental conditions. 27
Regulation of Physiological In Vivo Vasodilation Under Hypoxia Depends on Reduction of Endogenous Nitrite via Myoglobin
In light of relatively high levels of nitrite in the vessel walls compared with other tissues and blood 35 and the demonstrated nitrite-reductase activity of vascular myoglobin, we investigated acute in vivo responses to hypoxia using Mb ϩ/ϩ and Mb Ϫ/Ϫ mice, which have comparable levels of nitrite ( Figure IIA in the online-only Data Supplement). Anesthetized mice were intubated and mechanically ventilated (scheme in Figure 2A ). Hypoxia was then induced, and the immediate effects on hemodynamics were recorded. In Mb ϩ/ϩ mice, we observed a reduction in systolic and diastolic blood pressure within 2 to 4 minutes of hypoxia to a lower plateau after 5 to 10 minutes. In Mb Ϫ/Ϫ mice, the acute blood pressure response was reduced by up to 54% ( Figure 2B and 2C) , and instead we saw a continuing but gradual decline in pressure.
Nitrite-Induced Hypoxic Vasodilation Depends on NO ⅐ /Soluble Guanylate Cyclase/cGMP Signaling Pathway
The in vivo differences between Mb ϩ/ϩ and Mb Ϫ/Ϫ mice were consistent with significantly higher levels of nitroso species in aortic tissue relating to higher rates of NO ⅐ production in Mb ϩ/ϩ mice ( Figure 3A ; comparable normoxic values and N-nitrosamine levels in Figure IIB through IID in the online-only Data Supplement). Given the smaller sample size of these approaches, P values should not be overinterpreted. However, this was further evidenced by higher plasma cGMP levels and in aortic tissue of Mb Ϫ/Ϫ mice ( Figure 3B ; relevant normoxic baseline values are in Figure IIE and IIF in the online-only Data Supplement). These cGMP levels were quantified by competitive enzyme immunoassay in excised thoracic aortas incubated under hypoxia with 10 mol/L nitrite for 10 minutes. 36 This suggests that nitrite-dependent formation of NO ⅐ via deoxymyoglobin significantly elevates the cellular signaling molecule cGMP. Using an ex vivo bioassay with phenylephrine-constricted Mb ϩ/ϩ and Mb Ϫ/Ϫ aortic rings, we then assessed the effect of the NO ⅐ scavenger cPTIO and the soluble guanylate cyclase (sGC) inhibitor ODQ on vasorelaxation under 10 mol/L nitrite. In Mb ϩ/ϩ vessels, both inhibitors significantly but not totally 33 inhibited the nitritedependent vasodilatory response ( Figure 3C ). To quantify the production of NO ⅐ , we used electron paramagnetic resonance spectroscopy on single excised aortas that were preincubated with 100 mol/L nitrite under hypoxia (1% O 2 , pH 7.4). A spin trap was generated anoxically from ferrous sulfate and diethyldithiocarbamate [0.2 mmol/L Fe-(DETC) 2 ] and added to trap any NO ⅐ . The resulting NO-Fe-(DETC) 2 electron paramagnetic resonance signal was used to quantify the amount of NO ⅐ generated over a 10-minute period. Figure 3D shows that the signal obtained from Mb ϩ/ϩ mice was distinctive from that of Mb Ϫ/Ϫ mice. Quantification of the NO-Fe-(DETC) 2 electron paramagnetic resonance signal ( Figure 3E ) revealed a Ϸ50% decrease of NO ⅐ formation in Mb Ϫ/Ϫ aortas relative to vessels from Mb ϩ/ϩ mice. Taken together, these data suggest that the nitrite-induced, myoglobin-dependent, in vivo vasodilation depends directly on the canonical NO ⅐ /sGC/cGMP pathway located in the vessel wall. 
Hypoxic Vasodilation Is Independent of Enzymatic NO ⅐ Production With Normal Responses in eNOS Ϫ/Ϫ and iNOS Ϫ/Ϫ Mice
NO ⅐ could be generated by O 2 -dependent eNOS or inducible NOS (iNOS) rather than by myoglobin. To explore the involvement of eNOS/iNOS in the initiation of in vivo hypoxic vasodilation, we used eNOS Ϫ/Ϫ and iNOS Ϫ/Ϫ mice. eNOS Ϫ/Ϫ mice and, to a lesser extent, iNOS Ϫ/Ϫ mice displayed somewhat higher vascular pressures than the corresponding wild-type mice (genetic background: C57BL/6), but despite this, both displayed pronounced hypoxic vasodilation responses that in relative terms were indistinguishable from those of their respective wild-type controls ( Figure 3F and Figure III of the online-only Data Supplement). This is incompatible with a role for eNOS and iNOS in hypoxic vasodilation.
Effects of Escalating Nitrite Doses on Hypoxic Vasodilation In Vivo Depend on the Presence of Myoglobin
To further demonstrate the role of nitrite as the principal source of NO ⅐ , we assessed the in vivo myoglobin-dependent effects on blood pressure under steady state hypoxia using different exogenous nitrite doses. Pharmacological concentrations of exogenous nitrite have been demonstrated to relax preconstricted isolated arteries. 5, 17, 18 In our experimental protocol, endogenous NO ⅐ synthesis was inhibited pharmacologically with the use of L-NIO, 4 and mice were exposed for 30 minutes to hypoxia (ventilation with 10% O 2 to reach a final PaO 2 of 30 mm Hg). Exogenous nitrite was then administered intravenously, and hemodynamics were monitored (schema in Figure 4A ). Nitrite at 16.7 mol/kg caused a significantly greater reduction in blood pressure in Mb ϩ/ϩ than in Mb Ϫ/Ϫ mice ( Figure 4B ), and the same but smaller effects were evident at 1.67 mol/kg nitrite, which is a physiological dose ( Figure 4C ; absolute values and effects of exogenous nitrite under normoxia as controls are shown in Figures IV and V of the online-only Data Supplement).
If NO ⅐ was generated from applied nitrite via vascular myoglobin, then we anticipated the formation of ironnitrosylated myoglobin products 30, 37 
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solution, which directly links the nitrite-dependent production of NO ⅐ to the myoglobin protein itself and not to other heme proteins in smooth muscle, including cytoglobin, 38 which should occur in Mb Ϫ/Ϫ mice. Other potential nitrite reduction mechanisms 33, 39, 40 could also be negated by using ex vivo aortic ring preparations under hypoxic conditions. Thus, Figure 5B shows that neither the specific inhibition of XOR or aldehyde oxidase nor the absence of eNOS by removal of the endothelium affected the nitrite-induced (10 mol/L) vasodilation or the impact of myoglobin.
Nitrite-Driven Hypoxic Vasodilation via Vascular Myoglobin Is Not Related to Changes in Cardiac Output
Finally, hypoxic vasodilation might be linked to mechanisms of cardiac origin, either through reduced cardiac output or by N]nitrite and spin trap alone displayed no electron paramagnetic resonance signal. E, Quantitative analysis of these data revealed significantly higher amplitudes in Mb ϩ/ϩ aortas compared with Mb Ϫ/Ϫ vessels (meanϮSD; nϭ3; *Pϭ0.018). F, In vivo vasodilation is sustained in mice lacking endothelial or inducible NO synthase (eNOS/iNOS). eNOS and iNOS are major alternative sources for NO ⅐ under normoxia, but ablation of either gene failed to affect the vasodilatory responses in vivo. Thus, hypoxically induced vasodilation following the schema in Figure 2A was not reduced in eNOS Ϫ/Ϫ (nϭ6) and iNOS Ϫ/Ϫ (nϭ5) compared with the corresponding wild-type (WT) (C57BL/6) mice (nϭ5). Under normoxia, the baseline pressures remained stable throughout ( Figure II in the online-only Data Supplement) (values are meanϮSEM). Psys indicates systolic blood pressure; Pdias, diastolic blood pressure.
transfer of cardiac NO ⅐ to vascular smooth muscles. The former is unlikely because we found sustained or even enhanced heart functions during hypoxic challenge using a pressure-volume catheter placed in the left ventricle ( Figure 6A and Figure VI in the online-only Data Supplement), perhaps because of a decrease in afterload. In addition, Figure 6B shows that the circulating NO ⅐ pool represented by nitrite and nitroso compounds in the plasma was identical in both species under hypoxia and was unaffected by the absence of myoglobin, which argues against any influence on vasodilation of NO ⅐ generated by the heart. 15 N]NO as detected by electron paramagnetic resonance spectroscopy (with deoxygenated myoglobin solution as authentic control). B, Nitrite reduction to vasodilatory NO ⅐ was independent of xanthine oxidoreductase (inhibited by 100 mol/L allopurinol, 10 mol/L diphenyliodonium [DPI]), aldehyde oxidase (50 nmol/L raloxifen), or mechanisms located in the endothelial layer (Endothel.) Compared with untreated controls, no significant decrease in vasorelaxation was detected, whereas a significant difference between wild-type (Mb ϩ/ϩ ) and myoglobin-deficient (Mb Ϫ/Ϫ ) aortic rings remained detectable (meanϮSD; nϭ3; *PϽ0.05, **PϽ0.01).
Discussion
Although NO ⅐ is known to be involved as a trigger in hypoxic vasodilation, the source of NO ⅐ remains unclear. Plasma and vascular nitrite may provide an alternative source of NO ⅐ , but questions remain relating to the activator of nitrite, the exact role of heme globins, and the relevance of endogenous nitrite in the regulation of physiological functions. Our present study seeks to address these current controversies.
We here show that (1) endogenous nitrite, reduced by vascular myoglobin to bioactive NO ⅐ , is a regulator of the physiological vasodilatory response to hypoxia; (2) heme globin-related nitrite signaling via vascular myoglobin activates the wellestablished NO ⅐ /sGC/cGMP signaling pathway; and (3) this occurs independently of the NOS system, other potential nitritereductases, and hypoxia-modified cardiac function.
Role of Heme Globins
Nitrite-reductase activity has been identified in a variety of different proteins ranging from XOR, 36 cytochrome c oxidase, 41 cytochrome c, 42 to eNOS. 40 Comparable activity was also described for heme globins (eg, hemoglobin and myoglobin), 4, 19, 26 and neuroglobin has emerged recently as a novel redox-regulated nitrite-reductase. 28 Because heme globins can also react with NO ⅐ to form stable nitrosyl-heme complexes that may limit NO ⅐ bioavailability, a role for heme globin-driven NO ⅐ signaling has been questioned. Despite a general belief that myoglobin expression and function are limited to cardiomyocytes and striated muscle cells, recent experimental studies confirmed the existence of myoglobin in the vasculature and in a wide range of nonmuscle tissues of the hypoxia-tolerant carp. 31, 43 In the present study, we confirmed the presence of myoglobin transcript in smooth muscle layers of vessels and, using electron paramagnetic resonance spectroscopy, we confirmed myoglobin protein expression according to its distinct spectrum. 37 No transcript signal was evident in endothelial cells, as described recently for capillaries located in the central nervous system, 31 consistent with its presence in smooth muscle cells. We also showed that ablation of myoglobin in vascular tissue led to a marked decrease in reduction of nitrite to NO ⅐ , an observation that was independently verified by chemiluminescence and by electron paramagnetic resonance spectroscopy. By contrast, we failed to detect a role for XOR-mediated nitrite reduction, 36 and the contribution of acidic disproportionation 37 was negligible. The local presence of myoglobin in the vessel wall and a relevant myoglobin-dependent NO ⅐ generation implicate a role for this protein in the regulation of vascular functions under hypoxic conditions. Recent advances in understanding the role of this heme globin in cardiac function were achieved by taking advantage of the myoglobin knockout mouse. We were therefore able to demonstrate the relevance of cardiac myoglobin in nitrite reduction along the physiological O 2 gradient, thus restoring myocardial energy balance and yielding a much reduced infarct size. 26, 30 In the present study, we showed that genetic ablation of myoglobin impaired the hypoxia-induced vasodilation response by up to 54%, which points directly at myoglobin as a key component in the signal transduction mechanism necessary for hypoxic vasodilation. Although these observations specifically assess a role for myoglobin that accounts for more than half of the vasodilatory response, it is likely that multiple overlapping enzymatic and nonenzymatic pathways for nitrite reduction are present both in vascular tissue and in the blood compartment to allow for the graded reduction of nitrite to NO ⅐ at different oxygen tensions along physiological gradients. 24 These data therefore also highlight the potential for hemoglobin and red blood cells, neuroglobin, cytoglobin, and potentially undiscovered proteins to be involved in hypoxic nitrite reduction, accounting for the remainder of the vasodilatory response. Further investigations are needed to compare each of their relative contributions.
Role of Nitrite
Nitrite is not only the oxidation product of NO ⅐ but also a key reservoir for NO ⅐ in blood and cellular compartments. The largest component of the bodily nitrite provision derives from Either parameter shows a small increase that is incompatible with a contribution of cardiac function on hypoxic vasodilation (meanϮSEM). HR indicates heart rate; SV, stroke volume. B, Wild-type (Mb ϩ/ϩ ) and myoglobin-deficient (Mb Ϫ/Ϫ ) mice were anesthetized and intubated tracheally. After stabilization, mice were challenged with hypoxia (10% O 2 /90% N 2 , analogous to our in vivo protocol in Figure 2A ). Chemiluminescence and high-performance liquid chromatography were used to determine the plasma levels of nitrite and nitroso compounds (RNO). The latter comprises S-nitroso compounds (RSNO) and the remainder of bound NO ⅐ (RXNO; eg, N-nitroso compounds). No significant differences were measured between the 2 strains for either compound (meanϮSEM).
endogenous generation by NOS, and a smaller percentage is derived from nutritional sources. 44 Nitrite is present in the blood in nanomolar concentrations, whereas tissue levels in heart, liver, kidney, and particularly in the vasculature are comparably higher irrespective of the species investigated. 35, 45, 46 We and others have demonstrated recently that exogenous supplementation with pharmacological nitrite doses has implications for tissue protection under pathological conditions. Nitrite-related protection has been described for general disease states (eg, the cardiopulmonary resuscitation syndrome) 47 and for chronic and acute intervention regimens. 48, 49 Organ-specific protection has also been described for ischemic conditions of the brain, kidney, liver, and heart. 30, 49, 50 To substantiate the role of endogenous nitrite as a key effector by its myoglobin-induced activation to NO ⅐ , we investigated the involvement of the NO ⅐ /sGC/cGMP signaling pathway. A timely vasodilatory response requires the activation of smooth muscle cell sGC. 13 We showed significantly higher levels of cGMP when myoglobin was present, with this being a definitive indication of sGC activation on nitrite reduction. As expected, inhibition of sGC or scavenging of NO ⅐ did not abolish the vasodilatory effects completely. Furthermore, a specific role for NOS was excluded with the use of eNOS Ϫ/Ϫ and iNOS Ϫ/Ϫ mice. In addition, our experiments with different exogenous nitrite doses further confirmed that nitrite is the principal source of NO ⅐ via heme globin-driven signaling because exogenous nitrite at high and low pharmacological concentrations caused a significantly greater reduction in blood pressure in Mb ϩ/ϩ than in Mb Ϫ/Ϫ mice. Taken together, these new observations demonstrate that endogenous nitrite and the heme globin myoglobin play an essential role in activating the hypoxic vasodilation response. Our principal finding was that nitrite-induced responses under hypoxia in terms of the effect on vasodilation and subsequently on blood pressure were substantially reduced or absent in mice lacking myoglobin. This relates specifically to NO ⅐ generation from nitrite and the activation of the NO ⅐ / sGC/cGMP signaling pathway. Critically, we also showed that the reduced blood pressure induced in vivo by hypoxia was largely impaired under the absence of myoglobin as nitrite-reductase, whereas knockout of eNOS or iNOS had no such effect. We also showed in vivo that vasodilation can be induced under sustained hypoxia by application of a physiological dose of exogenous nitrite. That hypoxic vasodilation occurred in aortic rings stripped of endothelium indicates that the vascular mechanism is located in the remaining smooth muscle cells, which we show is the cytolocation of myoglobin transcripts and protein. However, it must be considered that these experimental models are an approximation of relevant vascular beds. In summary, these data provide evidence for a physiological role for endogenous nitrite and for a heme globin-related signaling mechanism in vivo. 
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